DAFTAR PUSTAKA

1. Chen Y, Rollins J, Paigen B. Toward understanding the molecular basis of

atherosclerosis with genetics and genomics. Cell Metab. 2007;6(3):16479.
2. Ingall T. Stroke Incidence, Mortality, Morbidity and Risk. J Insur Me. 2007;36:14352.
3. Kusuma Y, Venketasubramanian N, Kiemas LS, Misbach J. Burden of Stroke in
Indonesia. International Journal of Stroke. 2009 Okt;4.
4. Riskesdas. Riset Kesehatan Dasar 2007. Badan penelitian dan Pengembangan
Kesehatan Departemen Kesehatan RI. 2008 December.
5. Petrea ER, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Differences
in Stroke Incidence and Poststroke Disability in the Framingham Heart Study.
6.

Stroke. 2009;40:1032-1037.
National Stroke Association's Publications Comitte. Recurrent Stroke:Targets for

Managing Risk Ask the Experts Roundtable. 2009 December.

7. Stanley LC, Frank EA. Prevention of Recurrent Stroke. Stroke. 2006;37:1913-16.
8. Bang Y, Kim JS. Low-Molecular-Weight Heparin in Atherosclerotic Stroke, A
Surprising Resurrection of Anticoagulants?. Stroke. 2008;43:293-94.
9. Fromm A, Ariansen O, Haaland, Naess H, Thomassen L, Andreassen UW. Risk
factors and their impact on carotid intima-media thickness in young and middleaged ischemic stroke patients and controls: The Norwegian Stroke in the Young
Study. BMC Research Notes. 2014;7:176.
10. Groot Ed, Leuven SIv, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, et al.
Measurement of Carotid Intima-Media Thickness to Assess Progression and
Regression of Atherosclerosis. Nature Clinical Practice. 2008:1-9.
11. Della-Mortea D, Gardenera H, Denaroa F, Boden-Albalab B. Metabolic Syndrome
Increases Carotid ArteryStiffness: The Northern Manhattan Study. Int J Stroke. 2010
June;5(3):13844.
12. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and
the Risk of Cardiovascular Death and Acute Coronary and Cerebrovascular Events
in Men, The Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med.
2000;160:1160-1168.
13. The Aric Investigator. The Atherosclerosis Risk In Community (ARIC) Study:
Design And Objectives. Am. J. Epidemiol. 1989;129(4):687-702.
14. Stein HJ, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, et al. Distribution
and Cross Sectional Age-Related Increases of Carotid Artery Intima-Media
Thickness in Young Adults: The Bogalusa Heart Study. Stroke. 2004;35:2782-2787.
15. Georgios T, Konstantinos V, Christos P. Common Carotid Artery Intima-Media
Thickness and the Risk of Stroke Recurrence. Stroke. 2006;37:1913-16.
16. Prati P, Tosetto A, Vanuzzo D, Bader G. Carotid Intima Media Thickness and
Plaques Can Predict the Occurrence of Ischemic Cerebrovascular Events. Stroke.
2008;39:2470-76.

17. Hadi NU, Rukhsana, Awan KH, Iqbal N. Frequency of Carotid Artery Stenosis in
Ischemic Stroke by Using Carotid Doppler Ultrasonography in Teaching Hospital.
Gomal Journal of Medical Sciences. 2009; 7(2):82-85.
18. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of Obesity in
Intima Media Thickness of Carotid Arteries. OBESITY V. 2006;14:1-8.
19. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et
al. Cigarette Smoking and Progression of Atherosclerosis, Th. Atherosclerosis Risk
in Communities (ARIC) Study. JAMA. 1998;279(2):1-6.
20. Powell JT. Vascular damage from smoking: disease mechanisms atthe arterial wall.
Vascular Medicine. 1998;3:2128.
21. Yu Y, Sachiko M, Satomi SK, Jun H, Masaru K. Oxidants in cigarette smoke extract
modify low-density lipoproteinin the plasma and facilitate atherogenesis in the aorta
of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 2001;156:10917.
22. John AA, Rajat BS. The Pathophysiology of Cigarette Smoking and Cardiovascular
Disease An Update. J Am Coll Cardiol. 2004;43:17317.
23. Efstathios M, Georgios T, Eleni K, Kimon S, Christos P, Savas T, et al. Impact of
Prehypertension on Common Carotid Artery Intima-Media Thickness and Left
Ventricular Mass. Stroke. 2009;40:1515-18.
24. Hanefeld M, Koehler C, Henkel E, Fuecker K, Scaper, Temelkova-Kurtschiev. Postchallenge hyperglycaemia relates more strongly than fasting hyperglycaemia with
carotid

intima-media

thickness:

the

RIAD

Study.

Diabetic

Medicine.

2000;17(12):835-40.
25. Roxana D, Joanne SD, Wouter JJ, Ton RJ, Stokkel MP, Jan SW, et al. Increased
Carotid Intima-Media Thicknessas a Predictor of the Presence and Extentof
Abnormal Myocardial Perfusion in Type2 Diabetes. Diabetes Care. 2010;33:372
74.
26. Louise C, Thomas A, Bendix C, Lise T, Niels W. Carotid intima-media thickness in
individuals withand without type 2 diabetes: a reproducibilitystudy. Cardiovascular
Diabetology. 2010;9(40):1-7.
27. Thomas E, Jonathan H, Michiel H. Relationship between blood glucose and carotid
intima media thickness: A meta-analysis. Cardiovascular Diabetology. 2010;9(37):18.
28. Javier NF, Carlos I, Myron GD, George CW, Richard CG. Uric acid and serum
antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis. 2000;148:131
39.
29. Shuzo T, Ryuichi K, Tomo K, Masanori A, Morikazu O. Uric acid is an independent
risk factor for carotidatherosclerosis in a Japanese elderly populationwithout
metabolic syndrome. Cardiovascular Diabetology. 2012;11(2):1-9.
30. Germaine S, Corina S, Lavinia N, Fira MO, Gaita D, Oana DM, et al. The role of
hyperurecemia in endothelial dysfungtion induce by hypertension, Romanian. J.
Biophys. 2008;18(4),32936.

31. Klerk M, Verhoef P, Clarke R, Blom HJ, Schounten EG, et al. MTHFR 677C T
Polymorphism and risk of coronary heart disease. JAMA. 2002;288(16):2023-2032.
32. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the
methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism:
meta-analysis of 31 studies. Pathophysiol Haemost Thromb. 2002 MarApr;32(2):51-8.
33. Varga EA, Sturm AC, Misita CP, Moll S. Homocystein and MTHFR Mutations
Relations to Thrombosis and Coronary Artery Disease. Circulation. 2005;111:289293.
34. Paternoster L, Martinez-Gonzalez NA, Charleton R, Chung M, Lewis S, Sudlow
CLM. Genetic Effects on Carotid Intima- Media Thickness: Systematic Assessment
and Meta-Analyses of Candidate Gene Polymorphisms Studied in More Than 5000
Subject. Circ Cardiovasc Genet. 2010;3:15-2.
35. Badan Pusat Statistik Indonesia. Angka Harapan Hidup. 2014 [cited 2014 21 July];
Available from: http://www.datastatistik-indonesia.com.
36. World Health Organization. Global Health Observatory. Life expectancy. 2014
[cited 2014 21 July]. Available from: http://www.who.int/entity/gho/en/.
37. Air E, Kissela B. Diabetes, the Metabolic Syndrome, and Ischemic Stroke
Epidemiology and possible mechanisms. Diabetes care. 2007;30(12).
38. Kawamoto R, Ohtsuka N, Tomita H, Kamitani A, Oka Y. Metabolic syndrome and
carotid atherosclerosis: role of elevated blood pressure. Journal of atherosclerosis
and thrombosis. 2005;12(5):268-75.
39. Jae SY, Fernhall B, Heffernan KS, Kang M, Lee MK, Choi YH, et al. Chronotropic
response to exercise testing is associated with carotid atherosclerosis in healthy
middle-aged men. European Heart Journal. 2006;27:954-959.
40. Kallikazaros I, Stefanadis C. Carotid Artery Disease as a Marker for the Presence of
Severe Coronary Artery Disease in Patients Evaluated for Chest Pain. Stroke.
1999;30:1002-7.
41. Giannattasio C, Failla M, Emanuelli G, Grappiolo A, Boffi L, Corsi D, et al. Local
effects

of

atherosclerotic

plaque

on arterial

distensibility. Hypertension.

2001;38:1177-1180.
42. Mickleborough LL, Walker PM, Takagi Y, Ohashi M, Ivanov J, Tamariz M. Risk
factors for stroke in patients undergoing coronary artery bypass grafting. J Thorac
Cardiovasc Surg. 1996;112(5):1250-8
43. Simon A, Levenson J. Intima-media thickness, a new tool for diagnosis and
treatment of cardiovascular risk. Journal of Hypertension. 2002;20(2):159-69.
44. Kwon SU, Kim BJ, Kim SR, Kim DE, Kim HY, Lee JH, et al. The response of
carotid intima-media thickness to medical treatment is correlated with that of
intracranial atherosclerosis. J Clin Neurol. 2013;9:231-236.
45. Eigenbrodt ML, Evans GW, Rose KM, Bursac Z, Tracy RE, Mehta JL, et al.
Bilateral common carotid artery ultrasound for prediction of incident strokes using

intima-media

thickness

and

external

diameter:

an

observational

study.

Cardiovascular Ultrasound. 2013;11:22.

46. OLeary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, et al.
Carotid artery intima and media thickness as a risk factor for myocardial infarction
and stroke in older adults. The New England Journal of Medicine. 1999 January
7;340(1):14-22.
47. Turan MN, Demirci MS, Asci G, Yaprak M, Ok ES, Celtic A, et al. The Association
Between Progression of Carotid Artery Intima-Media Thickness and Cardiovascular
Events in Peritoneal Dialysis Patients. Turk Neph Dial Transpl. 2013;22(3):238-244.
48. Desvarieux M, Demmer RT, Jacobs DR, Papapanou PN, Sacco RL, Rundek T.
Changes in Clinical and Microbiological Periodontal Profiles Relate to Progression
of Carotid Intima-Media Thickness: The Oral Infections and Vascular Disease
Epidemiology Study. J Am Heart Assoc. 2013 December;2(6).
49. Freitas D, Alves A, Pereira A, Pereira T. Increased Intima-Media Thickness is
Independently Associated with Ischemic Stroke. Arq Bras Cardiol. 2012;98(6):497504.
50. Chin SO, Hwang JK, Rhee SY, Chon S, Hwang YC, Oh S, et al. Risk Factors for the
progression of intima-media thickness of carotid arteries: a 2-year follow-up study
in patients with newly diagnosed type 2 diabetes. Diabetes Metab J.
2013;37(5):365-74.
51. An WS, Son YK. Vascular calcification on plain radiographs is associated with
carotid intima media thickness, malnutrition and cardiovascular events in dialysis
patients: a prospective observational study. BMC Nephrology. 2013;14:27.
52. Panayiotou AG, Griffin M, Kouis P, Tyllis T, Georgiou N, Bond D, et al. Association
between presence of the metabolic syndrome and its components with carotid
intima-media thickness and carotid and femoral plaque area: a population study.
Diabetol Metab Syndr. 2013 August 20;5:44.
53. Huang TL, Hsu HC, Chen HC, Lin HC, Chien CY, Fang FM, et al. Long-term
effects on carotid intima-media thickness after radiotherapy in patients with
nasopharyngeal carcinoma. Radiat Oncol. 2013 November;8:261
54. Palinski W, Napoli C. Pathophysiological events during pregnancy influence the
development of atherosclerosis in humans. Trends Cardiovasc Med. 1999;9:205-14.
55. Stary HC, Chandler AB, Dinsmore RE. A definition of advanced types of
atherosclerotic lesions and a histological classification of atherosclerosis. A report
from the Committee on Vascular Lesions of the Council on Arteriosclerosis,
American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512-31.
56. Song Y, Manson JE, Tinker L. Circulating Levels of Endothelial Adhesion
Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women.
Diabetes. 2007 July;56:1898-04.
57. Reinders ME, Sho M, Robertson SW, Gehan CS, Briscoe DM. Proangiogenic
function of CD40 ligand-CD40 interactions. J Imunol. 2003;171:1534-41.

58. Roos R. Atherosklerosis an inflamatory disease. N Eng J Med. 1999;340:115-26.

59. Colman RW, Victor MJ, Alexander CW, James GN, Samuel G. Hemostasis and
Thrombosis, Basic Principles and Clinical Practice. Lippincott Williams & Wilkins.
2006:751- 23.
60. Piero V, Tanenbaum LN, Borden NM, Sen S, Eshkar N. CT Angiography in Acute
Ischemic Stroke Preliminary Results Stroke. 2002;33:276-278.
61. Vicente A. Control of vascular cell proliferation and migration by cyclin-dependent
kinase signalling: new perspectives and therapeutic potential. Cardiovascular
Research. 2004;63:11 21.
62. Hansson, GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J
Med. 2005;352:1685-95.
63. Norata GD, Catapano AL.

Molecular

mechanisms

responsible

for

the

antiinflammatory and protective effect of HDL on the endothelium. Vascular Health

and Risk Management. 2005;1(2):11929.
64. Shibata N, Glass CK. Regulation of macrophage function in inflammation and
atherosclerosis. Journal of Lipid Research. 2009:227- 282.
65. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inflammation in
atherosclerosis. J Nucl Med. 2007;48:1800-15.
66. Clappers N, Brouwer MA, Verheugt FWA. Antiplatelet Treatment for Coronary
Heart Disease. Heart. 2007;93:25865.
67. Virmani, R, Kolodgie FD, Burk AP, Farb A, Kolodgie FD. Pathology of the
vulnerable plaque. J Am Coll Cardiol. 2006;47:13-8.
68. Spagnoli LG, Mauriello A, Sangiorgi G. Extracranial trombotically active carotid
plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-52.
69. Packard RRS, Andrew H. Lichtman Innate and Adaptive Immunity in
Atherosclerosis. Semin Immunopathol. 2009;31(1):1-27.
70. Peter L, Paul RM, Gran HK. Inflammation in Atherosclerosis: From
Pathophysiology to Practice. J. Am. Coll. Cardiol. 2009;54:2129-38.
71. Peter L. Inflammation in atherosclerosis. JAMA. 2002;420:868-74.
72. Barton M, Minotti R, Haas E. Inflammation and Atherosclerosis. Circulation
Research. 2007;101:750-51.
73. Clarke MCH. Vascular Smooth Muscle Cell Apoptosis Induces Interleukin-1
Directed Inflammation. Circulation Research. 2010;106:363-72.
74. David LCW, Bikramjit D, Hongyun Y, Paul SE, Subodh V. Adipokines: molecular
links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol.
2005;288:2031-41.
75. Bath PM, Hassal DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and
prostacyclin, Divergence of inhibitory effects on monocyte chemotaxis and
adhesion to endothelium invitro. Arterioscler Thromb. 1991;11:254-60.
76. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood
flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia,
and hypertension. J Clin Invest. 1993;92:652-62.

77. Kathryn MJ, Ira T. Macrophages in the Pathogenesis of Atherosclerosis. J Cell.

2011:1-15.
78. Consigny PM. Pathogenesis of atherosclerosis. AJR Am J Roentgenol.
1995;164:553-8.
79. Demer LL, Tintut Y. Mineral exploration: search for the mechanism of vascular
calsification and beyond. Atherosclerosis Thromb Vasc Biol. 2003;23:1739-43.
80. Fuster V, Badimon JJ, Chesebro JH. The Pathogenesis of coronary artery disease
and the acute coronary syndroms. N Engl J Med. 1992;326:242-50.
81. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden
coronary death: a comprehensive morphological classification scheme for
atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-75.
82. Naghvi M, Liby P, Falk E. From vulnerable palque to vulnerable patient: a call for
new difinitions and risk assessment strategies: Part II. Circulation. 2003;108:17728.
83. Crowther MA. Pathogenesis of Atherosclerosis. ASH Education Book. 2005;1:43641.
84. Mitchell RSKV, Abbas AK, Fausto N. Robbins Basic Pathology: With Student
Consult Online Access, 8 ed. Philadelphia: Saunders;2007.
85. Vinay K, Abbas AK, Fausto, Mitchell RN. The Heart. In: Robbins basic Pathology
8th Edition. Philadelphia: Saunders Elsevier publications;2007:523-576.
86. Iglseder B, Cip P, Malimare L, Ladurner G, Paulweber B. TheMetabolicSyndrome
IsaStrongerRiskFactorforEarlyCarotidAtherosclerosisinWomenThaninMen.
Stroke.2005;36:12121217.
87. StenslandBuggeE,BnaaKH,JoakimsenO,NjlstadI. SexDifferencesinthe
RelationshipofRiskFactorstoSubclinicalCarotidAtherosclerosisMeasured15
YearsLater:TheTromsStudy.Stroke.2000;31:574581.
88. Stamatelopoulosa KS, Armenib E, Georgiopoulosa G, Kazania M, Kyrkoua K,
Stellos K, et al. Recently postmenopausal women have the same prevalence of
subclinical carotid atherosclerosis as age and traditional risk factor matched men.
Atherosclerosis. 2012;221(2):50813.
89. Madhuri, Chandra S, Jabbar A. Age Associated in Intima Media Thickness in
Adults. Indian J Physiol Pharmacol. 2010;54(4):371-375.
90. Zieskea AW, McMahanb A, McGill HC, Hommaa S, Takeia H, Malcoma GT, et al.
Smoking is associated with advanced coronary atherosclerosis in youthfor the
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
Atherosclerosis. 2005;180:8792.
91. Dawson JD, Sonka M, Blecha MB, Lin W, Davis PH. Risk factors associated with
aortic and carotid intimal-medial thicness in adolescents and young adults: the
Muscatine Offspring Study. J Am Coo Cardiol. 2009;53(24):2273-79.
92. Chiara B, Andrea P, Rodolfo P. Smoking and gender. Cardiovascular Research.
2002;53:56876.

93. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clinica

Chimica Acta. 2004;344:112.
94. Hajer GR, Van Haeften TW, Visseren FLJ. Adipose tissue dysfuntion in obesity,
diabetes, and vascular disease. European Heart Journal. 2008;29:2959-71.
95. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and
the vascular endothelium: mechanism of reduced nitric oxide bioavailability in
obese human. International Journal of Obesity. 2002;26(6):75464.
96. World Health Organization. BMI Classification. 2004 [cited 2014 21 July].
Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
97. Foresta C, Ferlin A, De Toni L, Lana A, Vinanzi C, Galan A, Caretta N. Circulating
endothelial progenitor cells and endothelial function after chronic Tadalafil
treatment in subjects with erectile dysfunction. Int J Impot Res. 2006;18(5):484-8.
98. Lane HA, Jamie SC, Jamie DS. Noninvasive assessment of preclinical
Atherosclerosis. Vascular Health and Risk Management. 2006;2(1)1930.
99. Zvonimir SK. Mechanisms of Endothelial Dysfunction Induced by Aging.
Circulation Research. 2007;101:640-41.
100.
Cade WT. Diabetes-Related Microvascular and Macrovascular Diseases in
the Physical Therapy Setting. PHYS THER. 2008;88:1322-35.
101.
Stauffera BL, Westbya CM, Christopher A. DeSouzaa Endothelin-1, aging
and hypertension. Curr Opin Cardiol. 2008;23(4):35055.
102.
Quehenberger P, Bierhaus A, Fasching P. Endothelin 1 transcription is
controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells.
Diabetes. 2000;49:1561-70.
103.
Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C. Determinants of
Arterial Wall Remodeling During Lipid-Lowering Therapy Serial Intravascular
Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive
Lipid Lowering Therapy (REVERSAL) Trial. Circulation. 2006;113:2826-34.
104.
Achmad TH, Winterscheidt A, Lindemann C, Rao GS. Oxidized low density
lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and
monocyte migration. Methods Find Exp Clin Pharmacol. 1997;19:153-9.
105.
Huebschann AG, Regensteiner JG, Vlassara H, Jane EB. Reusch, Diabetes
and Advanced Glycoxidation End Products. DIABETES CARE. 2006;29(6):142032.
106.

Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis:

epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81.

107.
Kaufmann PA, Gnecchi-Ruscone T, Schafers KP. Low Density Lipoprotein
Cholesterol and Coronary Microvascular Dysfunction in Hypercholesterolemia.
Journal of the American College of Cardiology. 2000;36(1):1-9.
108.
Silva IT, Mello APQ, Damasceno NRT. Antioxidant and inflammatory
aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2). Lipids in Health
and Disease. 2011:1-10.

109.

Uemura S, Matsushita H, Li W. Diabetes mellitus enhances vascular matrix

metalloproteinase activity: role of oksidatif stress. Circ Res. 2001;88:1291-8.

110.
Beer S, Feihl F, Ruiz J, Juhan-Vague I. Comparison of skin microvascular
reactivity with hemostatic markers of endothelial dysfunction and damage in type 2
diabetes. Vascular Health and Risk Management. 2008;4(6):144958.
111.
Dullaart RP, Vries RD, Tol AV, Sluiter WJ. Lower plasma adiponectin is a
marker of increased intima media thickness associated with type 2 diabetes mellitus
and with male gender. European Journal of Endocrinology. 2007;156:38794.
112.
Li-xin G, Qi P, Xiao-xia W, Hui L, Li-na Z, Jia-min, et al. Effect of short term
intensive multi therapy on carotid intima-media thickness in patients with newly
diagnosed type 2 diabetes mellitus. Chinese Medical Journal. 2008;121(8):687-90.
113.
Rogowicz-Frontczak A, Araszkiewicz A, Pilacinski S, ZozulinskaZiolkiewicz D, Wykretowics A, Wierusz-Wysocka B. Carotid intima-media
thickness and arterial stiffness in type 1 diabetic patients with and without
microangiopathy. Arch Med Sci. 2012 Jul;8(3):484490.
114.
Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, et al.
Combination of the Framingham Risk Score and Carotid Intima-Media Thickness
Improves the Prediction of Cardiovascular Events in Patients With Type 2 Diabetes.
Diabetes Care. 2012 Jan;35:178-180.
115.
Belibou C, Ancuta C, Ancuta E, Filos C, Chirieac R. Carotid Intima-Media
Thickness and Plaque as Surrogate Biomarkers of Atherosclerosis Among
Consecutive Women with Systemic Lupus Erythematosus. Rom J Morphol
Embryol. 2012;53(1):29-34.
116.
Marcos M, Rodrguez J, Sa nchez E, Alonso M, Magallo R, Vizcaino V, et
al. Carotid Intima Media Thicknessin Diabetics and Hypertensive Patients. Esp
Cardiol. 2011:10-101.
117.
Opara JU. The deadly quarter-the insulin resistance syndrome. South Med J.
1997;90:1162-68.
118.
Lee YH, Shin MH, Kweon SS. Alcohol consumption and carotid artery
structure in Korean adults aged 50 years and older. BMC Public Health. 2009:1-10.
119.
Polak JF, Pencina MJ, Pencina KM, ODonnell CO. Carotid wall Intima
Media Thickness and cardiovascular Events. The New England Journal of
Medicine. 2011;365(3):213-22.
120.
Karaseka D, Vaverkovaa H, Halenkaa M, Jackuliakovaa D, Frysaka Z,
Orsaga J, et al. Prehypertension in dyslipidemic individuals; relationship to
metabolic parameters and intima-media thickness. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 2012;156:20.
121.
Trindade M, Martucci RB, Burla AK, Oigman W, Neves MF, Araujo DV.
Evaluation of Clinical Variable associated with increased Carotid Intima-Media
Thickness in Middle-Aged Hypertensive Women. International Journal of
Hypertension. 2012:1-6.

122.

Jeong K, Wei Y, Sowers JR. Role of Mitochondrial Dysfunction in Insulin

Resistance. Circ Res. 2008;102:401-14.

123.
Djokomoeljanto R. Renin Angiotensin System and Atherosclerosis. In:
Tanuwidjojo S, Sungkar MA, Rifki S, editors. New Trends in Cardiovascular
Pharmacotherapy. Semarang: Universitas Diponegoro; 2005:122-32.
124.
Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and
pathological effects in the cardiovascular system. Am J Physiol Cell Physiol.
2007;292:82-97.
125.
Garrido AM, Griendling KK. NADPH Oxidases and Angiotensin II Receptor
Signaling. Mol Cell Endocrinol. 2009;302(2):14858.
126.
Paul M, Mehr AP, Kreutz R. Physiology of Local Renin-Angiotensin
Systems. Physiol Rev. 2006;86:74703.
127.
Akishima Y, Yoshikiyo A, Yukio I , Zhang L. Role of macrophage and
smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in
the atherosclerotic development. Modern Pathology. 2005;18:36573
128.
Rashid S, Genest J. Effect of Obesity on High-density Lipoprotein
Metabolism. Obesity. 2007;15:287588.
129.
Mathieu P, Philippe P, Jean-Pierre D. Metabolic Syndrome, The Danger
Signal in Atherosclerosis. Vasc Health Risk Manag. 2006;2(3):28502.
130.
Francone OL. SR-BI A New Player in an Old Game. Arterioscler Thromb
Vasc Biol. 2003;23:1486-87.
131.
Anke K, Harchaoui KE, van der Steeg WA, Boekholdt SM. Cholesteryl Ester
Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein
Cholesterol Levels. Arterioscler Thromb Vasc Biol. 2006;26:706-15.
132.
Perdomo G, Kim DH, Zhang T, Qu S, Thomas EA. A role of apolipoprotein
D in triglyceride metabolism. J. Lipid Res. 2010;51:129811.
133.
Saranteas, Zotos T, Lolis N, Stranomiti, Mourouzis J, Chantzi, et al.
Mechanisms of ketamine action on lipid metabolism in rats. European Journal of
Anaesthesiology. 2005;22(3):222-26.
134.
Knopp RH, Pathmaja P. Oxidized LDL and abdominal obesity: a key to
understanding the metabolic syndrome. Am J Clin Nutr. 2006;83:12.
135.
Krauss RM. Lipids and Lipoproteins in Patients With Type 2 Diabetes.
Diabetes Care. 2004;27(6):1496-04.
136.
Pandolfi A, De Filippis EA. Chronic hyperglicemia and nitric oxide
bioavailability play a pivotal role in pro-atherogenic vascular modifications. Genes
Nutr. 2006:195-08.
137.
Agarwal A, Nandipati KC, Sharma RK, Zippe CD. Role of Oksidatif Stress
in the Review Pathophysiological Mechanism of Erectile Dysfunction. J Andrology.
2006;27(3):335-348.
138.
Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J
Lipid Res. 2009;50:76-81.

139.

Tall AR. Cholesterol efflux pathways and other potensial mechanisms

involved in the athero-prospective effect of high density lipoproteins. J Int Med.

2007;263:256-73.
140.
Gutierrez J, Ballinger SW, Usmar VMD, Victor M. Free Radicals,
Mitochondria, and Oxidized Lipids, The Emerging Role in Signal Transduction in
Vascular Cells. Circulation Research. 2006;99:924-32.
141.
Tsimikas S, Brilakis ES, Miller ER. Oxidized Phospholipids, Lp(a)
Lipoprotein, and Coronary Artery Disease. N Engl J Med. 2005;353:46-57.
142.
Sudhir K. Lipoprotein-associated phospholipase A2, vascular inflammation
and cardiovascular riskprediction. Vascular Health and Risk Management.
2006;2(2):15356.
143.
Kuller LH, Gregary G, Jerome C. Lipoprotein Particles, Insulin, Adiponectin,
C-Reactive Protein and Risk of Coronary Heart Disease among Men with Metabolic
Syndrome. Atherosclerosis. 2007;195(1):12228.
144.
Christen W, Ajani UA. Blood Levels of Homocysteine and Increased Risks of
Cardiovascular Disease. Arch Intern Med. 2000;160:422-34.
145.
Hodis HN, Mack WJ, Dustin L, Mahrer PR. High-Dose B Vitamin
Supplementation and Progression ofSubclinical Atherosclerosis A Randomized
Controlled Trial. Stroke. 2009;40:730-36.
146.
Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction,
cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis
Research & Therapy. 2007;7(3):634-43.
147.
Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC. Synergism in
hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Cardiovascular Diabetology. 2010;9:49:1-13.
148.
McKay DL, Perrone G, Rasmussen H. The Effects of a Multivitamin/Mineral
Supplement on Micronutrient Status, Antioxidant Capacity and Cytokine Production
in Healthy Older Adults Consuming a Fortified Diet. J Am Coll Nutr.
2000;19(5):613-21.
149.
De Luca G, Suryapranata H, Gregorio G. Homocysteine and Its Effects on InStent Restenosis. Circulation. 2005;112:307-11.
150.
erban C, Drgan S, Christodorescu R, uan L, Mozo I, Caraba A, et al.
Association of Serum Uric levels and Carotid Intima Thickness with the Numbers of
Organ Damaged in Hypertensive Patients. International Journal of Collaborative
Research on Internal Medicine & Public Health. 2011;3(1).
151.
Mazzali M, Kanellis J, Han L. Hyperuricaemia induces a primary renal
arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol
Renal Physiol. 2002;282:991-97.
152.
Feig D, Kang DH ,Richard J. Uric Acid and Cardiovascular Risk.
2008;359(17):1811-21.

153.

Panoulas H, Milionis J, Douglas KMJ. Association of serum uric acid with

cardiovascular disease in rheumatoid arthritis. Rheumatology. 2007;46:146670.

154.
Johnson RJ, Gaucher EA, Sautin YY, Henderson GN. The Planetary Biology
of Ascorbate and Uric acid and their Relationship with the Epidemic of Obesity and
Cardiovascular Disease. Med Hypotheses. 2008;71(1): 2231.
155.
Hediger MA, Johnson RJ, Miyazaki H. Molecular Physiology of Urate
Transport. J. Biol. Chem. 2010;285(45):35123-32.
156.
Watanabe S, Kang DH, Feng L. Uric acid, hominoid evolution, and the
pathogenesis of salt-sensitivity. Hypertension. 2002;40:355-60.
157.
Baldwin W, McRae S, Marek G, Wymer D. Hyperuricemia as a Mediator of
the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model
of the Metabolic Syndrome. Diabetes. 2011;60:125869.
158.
Varga EA, Sturm AC, Misita CP, Moll S. Homocysteine and MTHFR
mutations: relation to thrombosis and coronary artery disease. Circulation. 2005
May; 111(19):289-93.
159.
Finkelstein JD. The metabolism of homocysteine: pathways and regulation.
Eur J Pediatr. 1998; 157:540-44.
160.
Leclerc
D,
Sibani
S,
Methylenetetrahydrofolate

Rozen

Reductase

R.

Molecular

(MTHFR)

and

Biology

of

Overview

of

Mutations/Polymorphisms. In: Madame Curie Bioscience Database [Internet].

Austin

(TX):

Landes

Bioscience;

2000-.

Available

from:

http://www.ncbi.nlm.nih.gov/books/NBK6561/
161.
Goyette P, Sumner JS, Milos R. Human methylenetetrahydrofolate reductase:
Isolation of cDNA, mapping and mutation identification. Nature Genet. 1994;
7:195200.
162.
Guenther BD, Sheppard CA, Tran P. The structure and properties of
methylenetetrahydrofolate reductase from Escherichia coli suggest how folate
ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999; 6:359365.
163.
Frosst P, Blom HJ, Milos R. A candidate genetic risk factor for vascular
disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet.
1995; 10:111113.
164.
Deeparani T, Pillai MR, Elavazhagan T. Detection of MTHFR C677T and
A1298C Gene Polymorphism in Congenital Heart Disease. Middle-East J. Sci. Res.,
2009; 4(2): 127-132.
165.
Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the
methylenetetra-

hydrofolate

reductase

gene

and

the

risk

of

venous

thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb.

2002; 32:5158.
166.
Klerk M, Verhoef P, Clarke R, Blom H, Kok F, Schouten E. MTHFR 677C-T
polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002;
288:20232031.

167.

Stefania M, Simeone C, Melissa LW, Pierre P. Vascular gene expression in

mice overexpressing human endothelin-1 targeted to the endothelium. Physiol.

Genomics. 2011;43:148-60.
168.
Harris JD, Vanessa E, James OS. ApoE gene therapy to treat hyperlipidemia
and atherosclerosis. Current Opinion in Molecular Therapeutics. 2006;8(4):1-13.
169.
Dickstein DL, Jesica W, Hannah B. Role of Vascular Risk Factors and
Vascular Dysfunction in Alzheimer's Disease. Mt Sinai J Med. 2010;77(1):82102.
170.
Sturgeon JD, Aaron F, Molly BS. Apolipoprotein E Genotype and Incident
Ischemic Stroke : The Atherosclerosis Risk in Communities Study. Stroke.
2008;36:2484-86.
171.
Meer IM, Witteman JCM. Apolipoprotein E genotype, smoking and
cardiovascular disease. J Hypertens. 2002;20:2327-29.
172.
Haan NM, Elizabeth MR. Apolipoprotein E Genotype and Cardiovascular
Diseases in the Elderly. Curr Cardio Risk Rep . 2010;4:36168.
173.
Vidal PM, Bongard V, Ruidavets JB, Fauvel J, Broutin HH, Perret B, et al.
Obesity and alcohol modulates the effect of apolipoprotein E polymorphism on
lipids and insulin. Obes Res. 2003;10:1200-06.
174.
He LN, Recker RR, Deng HW, Dvornyk V. A polymorphism of
apolipoprotein E (APOE) gene is associated with age at natural menopause in
Caucasian females. Maturitas. 2009;62(1): 3741.
175.
Tamam Y, Tasdemir TN, Taman B, Iltumur K. Apolipoprotein E genotype in
patients with cerebrovascular diseases and its effect on the disease outcome. Int J
Neurosci. 2009;119:919-35.
176.
Ravaglia G, Paola F, Fabiola M. Apolipoprotein E e4 allele affects risk of
hyperhomocysteinemia in the elderly. Am J Clin Nutr. 2006;84:147380.
177.
Gregg DJ, Sing CF. Apolipoprotein E polymorphism and atherosclerosis.
Arterioscler Thromb Vasc Biol. 1988;8:1-21.
178.
Myllykangas L, Gam N, Sulkava R, Polvikoski. Apolipoprotein E (APOE)
and lipoprotein lipase (LPL) gene variants and carotid atherosclerotic lesion in the
oldest old: A population-based autopsy study. Arch Gerontol Ger. 2008:108-12.
179.
Wang B, Zhao H, Zhao L, Dai X, Wang D, Cao J. Association of genetic
variation in apolipopritein E and low density lipoprotein receptor with ischemic
stroke in Northern Han Chinese. J Neurol Sci. 2009;276(1-2):118-22.
180.
Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid Intima-Media
Thickness, Plaques, and FraminghamRisk Score as Independent Determinants of
Stroke Risk. Stroke. 2005;36:1741-45.
181.
Ewoud AT, Anton SF, Jacqueline DG. What is the role of non-invasive
measurementsof atherosclerosis in individual cardiovascular risk prediction?.
Clinical Science. 2007;112:50716.
182.
Lee EJ, Kim HJ, Bae JM, Kim JC, Han CS. Relevance of common carotid
intima-media thickness and carotid plaque as risk factors for ischemic stroke in
patients with type 2 diabetes mellitus. ANJR Am J Neuroradiol. 2007;28:916 -19.

183.

Norbert N, Derex L, Douek P. The Vulnerable Carotid Artery Plaque Current

Imaging Methods and New Perspectives. Stroke. 2005;36:2764-72.

184.
Viikari JS, Raitakari OT, Simell O. Nutritional Influences on lipids and future
atherosclerosis beginning prenatally and during childhood. Curr Opin Lipidol.
2002;13(1):11-8.
185.
Kozakova M, Palombo C, Morizzo C, Nolan JJ, Konrad T, Dekker JM, et al.
Gender-specific differences in carotid intima-media thickness and its progression
over three years: a multicenter European study. Nutr Metab Cardovasc Dis.
2013;23(2):151-8.
186.
Sinning C, Wild PS, Echevarria FM, Wilde S, Schnabel R, Lubos E, et al. Sex
differences in early carotid atherosclerosis (from the community-based GutenbergHeart Study). Am J. Cardiol. 2011;107(12):1841-7.
187.
El-Hafez HA, Elrakhawy MM, El-Baiomy AA, El-Eshmawy MM. Carotid
Intima Media Thickness Is Independently Associated with Male Gender, Middle
Age, and IGF-1 in Metabolically Healthy Obese Individuals. ISRN Obesity. 2014.
188.
Kallio K, Jokinen E, Saarinen M, Hamalainen M, Volanen I, Kaitosaari T, et
al. Arterial intima-media thickness, endothelial function, and apolipoproteins in
adolescents frequently exposed to tobacco smoke. Cirs Cardiovase Qual Outcomes.
2010;3:196-203.
189.
Recio-Rodriguez JI, Gomez-Marcos MA, Alonso MCP, Martin-Cantera C,
Ibanez-Jalon E, Melguizo-Bejar A, et al. Association between smoking status and
the parameter of cascular structure and function in adults: result from the EVIDENT
study. BMC Cardiovascular Disorders. 2013;13:109.
190.
Mustafa ZM. Effect of cigarettes smoking on common arteries intima media
thickness in current smokers. Ozean Journal of Applied Sciences. 2012;5(4):259269.
191.
Zakapoulos NA, Tsivgoulis G, Papamichael C, Spengos K, Manios E, et al.
Time rate of blood pressure variation is associated with increased common carotid
intima-media thickness. Hypertension. 2005;45:505-5012.
192.
Xiong H, Wu D, Tian X, Lin WH, Li C, Zhang H, et al. The relationship
between the 24 h blood pressure variability and carotid intima-media thickness: a
compared study. Hindawi. 2013;10:1-9.
193.
Kollias A, Psilopatis I, Karagiaouri E, Glaraki M, Grammatikos E,
Grammatikos EE, et al. Adiposity, blood pressure, and carotid intima-media
thickness in Greek adolescents. Obesity. 2013;21:1013-1017.
194.
Diaz EdM, Giollo LT, Martinelli DD, Mazeti C, Junior HM, Vilela-Martin JF,
et al. Carotid intima-media thickness is associated with cognitive deficiency in
hypertensive patients with elevated central systolic blood pressure. Caridiovascular
Ultrasound. 2012;10:41.
195.
Rueda-Clausen CF, Lopez-Jaramillo P, Luengaz C, Oubina MP, Cachofeiro V,
Lahera V. Inflammation but not Endothelial Dysfunction is Associated with the

Severity of Coronary Artery Disease in Dyslipidemic Subjects. Mediators of

Inflammation. 2009:1-8
196.
Sun P, Dwyer KM, Merz CNB, Sun W, Johnson CA, Shircore AM, et al.
Blood pressure, LDL cholesterol, and intima-media thickness. 2000;20:2005-2010.
197.
Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JSA, Hartiala JJ, et al.
Increased arterial intima-media thickness and in vivo LDL oxidation in young men
with borderline hypertension. Hypertension. 2000;36:929-933.
198.
Saha A, Sinha PK, Paul R, Bandyopadhyay R, Biswas K, Banerjee AK. Study
of carotid intimamedia thickness and its correlation with novel risk factors in
ischemic stroke. 2011;16(1):25-31.
199.
Stella S, Vasilios K, Christina K, Nikos Z, Andreas K. Blood pressure and
carotid artery intima-media thickness in children and adolescents: the role of
obesity. Hellenic J Cardiol. 2011;53:41-47.
200.
Gayathri R, Chandni R, Udayabhaskaran V. Carotid artery intima media
thickness in relation with atherosclerotic risk factors in patients with type 2 diabetes
mellitus. JAPI. 2012;60:20-24.
201.
Sinha PK, Santra G, De D, Saha A, Biswas K, Bhattacharya P, et al. Carotid
intima-media thickness in type 2 diabetes mellitus with cardiac autonomic
neuropathy. JAPI. 2012;60:14-18.
202.
Sainani GS, Nazia RK. Carotid artery intima media thickness- a correlative
study of diabetics with postprandial hyperglycemia versus controls with euglycemia.
Medicine Update. 2012;22:298-303.
203.
Yashimitsu Y, Mineo K, Hideko N, Kenya S. Carotid intima-media thickness
in Japanese type 2 diabetic subjects. Diabetes Care. 2000;23:1310-1315.
204.
Tavil Y, Kaya MG, Oktar SO, Sen N, Oktay K, Yazici HU, et al. Uric acid
level and its association with carotid intima-media thickness in patients with
hypertension. Atherosclerosis. 2008;197(1):159-163.
205.
Caliskan M, Guven A, Ciftci O, Ozulku M, Gunday M, Barutcu I, et al.
Serum uric acid and carotid artery intima media thickness in patients with masked
hypertension. Acta Cardiol. 2014;69(4):417-423.
206.
Linnebank M, Moskau S, Farmand S, Fliessbach K, Kolsch H, Bos M.
Homocysteine and carotid intima-media thickness in German population. Stroke.
2006;37:2840-2842.
207.
Ntalos G, Savopoulos C, Hatzitolios A, Ekonomou I, Destanis E,
Chryssogonidis I, et al. Homocysteine and carotid intima-media thickness in
ischemic stroke patients are not correlated. Nuropsychiatric Disease and Treatment.
2008;4(2):477-479.
208.
Kandil ME, Anwar GM, Fatouh A, Salama N, Ahmed A, Elabd E, et al.
Relation between serum homocysteine and carotid intima-media thickness in obese
Egyptian children. J Clin Basic Cardiol. 2010;13:8-11.

209.

Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate Reductase Gene Variants

and Congenital Anomalies: A Huge Review. American Journal of Epidemiology.

2000;151(9).
210.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA. A candidate genetic
risk factor for vascular disease: A common mutation in methylenetetrahydrofolate
reductase. Nature Genet. 1995;10:111113.
211.
Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM. The
Methylenetetrahydrofolate Reductase 677CrT Polymorphism as a Modulator of a B
Vitamin Network with Major Effects on Homocysteine Metabolismb. The American
Journal of Human Genetics. 2007;80:846-855.
212.
Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY. Association of
Apolipoprotein E Gene Polymorphism With Ischemic Stroke Involving LargeVessel Disease and Its Relation to Serum Lipid Levels. Journal of Stroke and
Cerebrovascular Diseases. 2007;16(4):160166.
213.
Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma
triglyceride levels by apoE phenotype: a meta-analysis. Journal of fipid Research.
1999;33:447-454.
214.
Ivanova R, Puerta S, Garrido A, Cueto I, Ferro A, Ariza MJ, et al.
Triglyceride levels and apolipoprotein E polymorphism in patients with acute
pancreatitis. Hepatobiliary Pancreat Dis Int. 2012;11(1): 97-101.
215.
Cardona F, Tinahones FJ, Collantes E, Escudero A, Garca-Fuentes E,
Soriguer FJ. The elevated prevalence of apolipoprotein E2 in patients with gout is
associated with reduced renal excretion of urates. Rheumatology. 2003;42:468472.
216.
Wu J, Qiu L, Guo XZ, Xu T, Cheng XQ, Li PC, et al. Apolipoprotein E Gene
Polymorphisms Are Associated with Primary Hyperuricemia in a Chinese
Population. 2014;9(10).